Recommending enhanced seasonal influenza vaccines in adults age 65 and older could have wide-ranging impacts on influenza burden

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

Recommending enhanced seasonal influenza vaccines in adults age 65 and older could have wide-ranging impacts on influenza burden

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

i

Recommending enhanced seasonal influenza vaccines in adults age 65 and older could have wide-ranging impacts on influenza burden

February 23, 2022
By Morris, Sinead
Series: ACIP meeting Influenza

[PDF-261.73 KB]

English

Details Related Documents You May Also Like

Details:

Personal Author:

Morris, Sinead
Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. Epidemiology and Prevention Branch. Applied Research and Modeling Team.
Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2022 February 23-24 : Atlanta, GA)
Description:

03-influenza-morris-508.pdf
Series:

ACIP meeting Influenza
Document Type:

Presentation
Name as Subject:

Aged ; Aged, 80 and over ; Cost of Illness ; Epidemiological Models ; Influenza, Human ; ... More +

Aged ; Aged, 80 and over ; Cost of Illness ; Epidemiological Models ; Influenza, Human ; Influenza Vaccines ; Vaccination ; ACIP meeting: 2022 Feb 23-24 ; Aged ; Aged, 80 and over ; Cost of Illness ; Epidemiological Models ; Influenza, Human ; Influenza Vaccines ; Vaccination ; ACIP meeting: 2022 Feb 23-24 Less -
Genre:

Conference Publications
Volume:

202203
Issue:

100303
Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:

[+]

urn:sha256:a86d38a7904793cd482d73cdcc85f3e809c2c17bb963fe691569b1fe15168d3c
Download URL:

https://stacks.cdc.gov/view/cdc/114833/cdc_114833_DS1.pdf
File Type:

No Additional Files

More +

You May Also Like

Preliminary Work Group Interpretations of EtR and Next Steps

Personal Author:

Kobayashi, Miwako

February 29, 2024 | ACIP meeting Influenza

Description:

06-Pneumococcal-Kobayashi-508.pdf
Post-licensure safety surveillance of 20-valent pneumococcal conjugate vaccine (PCV20) among U.S. adults in the Vaccine Adverse Event Reporting System (VAERS)

Personal Author:

Moro, Pedro L.

February 29, 2024 | ACIP meeting Influenza

Description:

05-Pneumococcal-Moro-508.pdf

Checkout today's featured content at stacks.cdc.gov